Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder-Reference-Cited by-同舟云学术

Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder

Published:2022-01-31 Issue:3 Volume:46 Page:384-395
ISSN:0145-6008
Container-title:Alcoholism: Clinical and Experimental Research
language:en
Short-container-title:Alcohol Clin & Exp Res

Author:

Robinson Jason D.¹^ORCID,Cui Yong¹,Karam‐Hage Maher¹,Kypriotakis George¹,Versace Francesco¹,Ait‐Daoud Tiouririne Nassima²,Anthenelli Robert M.³,Cinciripini Paul M.¹

Affiliation:

1. Department of Behavioral Science The University of Texas MD Anderson Cancer Center Houston Texas USA

2. Department of Psychiatry and Neurobehavioral Sciences University of Virginia School of Medicine Charlottesville Virginia USA

3. Department of Psychiatry Pacific Treatment and Research Center University of California, San Diego, Health Sciences La Jolla California USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Psychiatry and Mental health,Toxicology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/acer.14771

Reference97 articles.

1. Diagnostic and Statistical Manual of Mental Disorders

2. A Randomized Trial Evaluating Whether Topiramate Aids Smoking Cessation and Prevents Alcohol Relapse in Recovering Alcohol-Dependent Men

3. Attenuation of cocaine-seeking behaviour by the AMPA/kainate receptor antagonist CNQX in rats

4. Ionotropic Glutamate Receptor Antagonists Modulate Cue-Induced Reinstatement of Ethanol-Seeking Behavior

5. Addiction Motivation Reformulated: An Affective Processing Model of Negative Reinforcement.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A scoping review of electroencephalographic (EEG) markers for tracking neurophysiological changes and predicting outcomes in substance use disorder treatment;Frontiers in Human Neuroscience;2022-10-17

2. Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review;Frontiers in Pharmacology;2022-10-03